The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock

Context: Cardiogenic shock (CS) still remains one of the main causes of death in acute myocardial infarction (AMI). Objective: The aim of this study was to evaluate the prognostic value of midregional (MR)-proadrenomedullin in AMI complicated by CS. Methods: Forty-seven consecutive patients were inc...

Full description

Saved in:
Bibliographic Details
Published in:Biomarkers 2017-05, Vol.22 (3-4), p.296-303
Main Authors: Supeł, Karolina, Kacprzak, Michał, Zielińska, Marzenna
Format: Article
Language:English
Subjects:
Acute Coronary Syndrome - complications
Adrenomedullin - blood
Adult
Aged
Aged, 80 and over
Cardiogenic shock
Hospital Mortality
Humans
Middle Aged
MR-proadrenomedullin
myocardial infarction
Myocardial Infarction - complications
Prognosis
Prospective Studies
Protein Precursors - blood
Shock, Cardiogenic - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-eb1784ff0d62d5770241ca3b6b45443c0aeb8f42554b96d875bc59fa52f91d5a3
cites cdi_FETCH-LOGICAL-c366t-eb1784ff0d62d5770241ca3b6b45443c0aeb8f42554b96d875bc59fa52f91d5a3
container_end_page 303
container_issue 3-4
container_start_page 296
container_title Biomarkers
container_volume 22
creator Supeł, Karolina
Kacprzak, Michał
Zielińska, Marzenna
description Context: Cardiogenic shock (CS) still remains one of the main causes of death in acute myocardial infarction (AMI). Objective: The aim of this study was to evaluate the prognostic value of midregional (MR)-proadrenomedullin in AMI complicated by CS. Methods: Forty-seven consecutive patients were included in our prospective observational study. All patients underwent coronarography and successful percutaneous coronary intervention (PCI). Plasma levels of MR-proADM were measured by a immunofluorescence method. The primary endpoint of the study, defined as cardiovascular death, occurred in 17 patients (36%). Results and conclusion: Elevated plasma level of MR-proADM, determined 24 h after diagnosis of CS could be a predictor of in-hospital mortality in patients with AMI complicated by CS.
doi_str_mv 10.1080/1354750X.2016.1252962
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_1354750X_2016_1252962</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835685778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-eb1784ff0d62d5770241ca3b6b45443c0aeb8f42554b96d875bc59fa52f91d5a3</originalsourceid><addsrcrecordid>eNp9kF1rHCEUhqU0ZNM0P6HFy97MVh2dce5aQtoGEgIhgd6J48euiaNbdbLsv4_LbnJZEI4cnnNezgPAF4yWGHH0HbeM9gz9XRKEuyUmjAwd-QDOcNt1DeOIftz_GW320AJ8yvkJIdySgZ-CBel7ztlAz8DLw9rATYqrEHNxCr5IPxsYLby9b2pb6mRCnIyevXcB1reRxZlQMty6soZSzcVAFVMMMu1g3gWdKl4708Y7JYvRcNxBJZN2cWVCTcjrqJ4_gxMrfTYXx3oOHn9dPVz-aW7ufl9f_rxpVD2jNGbEPafWIt0RzfoeEYqVbMdupIzSViFpRm4pYYyOQ6d5z0bFBisZsQPWTLbn4Nthb73l32xyEZPLyngvg4lzFpi3rON1M68oO6AqxZyTsWKT3FSvEhiJvXLxplzslYuj8jr39Rgxj1XU-9Sb4wr8OAAu2JgmuY3Ja1HkzsdkkwzKZdH-P-MVMXWTIg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835685778</pqid></control><display><type>article</type><title>The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Supeł, Karolina ; Kacprzak, Michał ; Zielińska, Marzenna</creator><creatorcontrib>Supeł, Karolina ; Kacprzak, Michał ; Zielińska, Marzenna</creatorcontrib><description>Context: Cardiogenic shock (CS) still remains one of the main causes of death in acute myocardial infarction (AMI). Objective: The aim of this study was to evaluate the prognostic value of midregional (MR)-proadrenomedullin in AMI complicated by CS. Methods: Forty-seven consecutive patients were included in our prospective observational study. All patients underwent coronarography and successful percutaneous coronary intervention (PCI). Plasma levels of MR-proADM were measured by a immunofluorescence method. The primary endpoint of the study, defined as cardiovascular death, occurred in 17 patients (36%). Results and conclusion: Elevated plasma level of MR-proADM, determined 24 h after diagnosis of CS could be a predictor of in-hospital mortality in patients with AMI complicated by CS.</description><identifier>ISSN: 1354-750X</identifier><identifier>EISSN: 1366-5804</identifier><identifier>DOI: 10.1080/1354750X.2016.1252962</identifier><identifier>PMID: 27788594</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Acute Coronary Syndrome - complications ; Adrenomedullin - blood ; Adult ; Aged ; Aged, 80 and over ; Cardiogenic shock ; Hospital Mortality ; Humans ; Middle Aged ; MR-proadrenomedullin ; myocardial infarction ; Myocardial Infarction - complications ; Prognosis ; Prospective Studies ; Protein Precursors - blood ; Shock, Cardiogenic - complications</subject><ispartof>Biomarkers, 2017-05, Vol.22 (3-4), p.296-303</ispartof><rights>2016 Informa UK Limited, trading as Taylor &amp; Francis Group 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-eb1784ff0d62d5770241ca3b6b45443c0aeb8f42554b96d875bc59fa52f91d5a3</citedby><cites>FETCH-LOGICAL-c366t-eb1784ff0d62d5770241ca3b6b45443c0aeb8f42554b96d875bc59fa52f91d5a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27788594$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Supeł, Karolina</creatorcontrib><creatorcontrib>Kacprzak, Michał</creatorcontrib><creatorcontrib>Zielińska, Marzenna</creatorcontrib><title>The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock</title><title>Biomarkers</title><addtitle>Biomarkers</addtitle><description>Context: Cardiogenic shock (CS) still remains one of the main causes of death in acute myocardial infarction (AMI). Objective: The aim of this study was to evaluate the prognostic value of midregional (MR)-proadrenomedullin in AMI complicated by CS. Methods: Forty-seven consecutive patients were included in our prospective observational study. All patients underwent coronarography and successful percutaneous coronary intervention (PCI). Plasma levels of MR-proADM were measured by a immunofluorescence method. The primary endpoint of the study, defined as cardiovascular death, occurred in 17 patients (36%). Results and conclusion: Elevated plasma level of MR-proADM, determined 24 h after diagnosis of CS could be a predictor of in-hospital mortality in patients with AMI complicated by CS.</description><subject>Acute Coronary Syndrome - complications</subject><subject>Adrenomedullin - blood</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cardiogenic shock</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>MR-proadrenomedullin</subject><subject>myocardial infarction</subject><subject>Myocardial Infarction - complications</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Protein Precursors - blood</subject><subject>Shock, Cardiogenic - complications</subject><issn>1354-750X</issn><issn>1366-5804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kF1rHCEUhqU0ZNM0P6HFy97MVh2dce5aQtoGEgIhgd6J48euiaNbdbLsv4_LbnJZEI4cnnNezgPAF4yWGHH0HbeM9gz9XRKEuyUmjAwd-QDOcNt1DeOIftz_GW320AJ8yvkJIdySgZ-CBel7ztlAz8DLw9rATYqrEHNxCr5IPxsYLby9b2pb6mRCnIyevXcB1reRxZlQMty6soZSzcVAFVMMMu1g3gWdKl4708Y7JYvRcNxBJZN2cWVCTcjrqJ4_gxMrfTYXx3oOHn9dPVz-aW7ufl9f_rxpVD2jNGbEPafWIt0RzfoeEYqVbMdupIzSViFpRm4pYYyOQ6d5z0bFBisZsQPWTLbn4Nthb73l32xyEZPLyngvg4lzFpi3rON1M68oO6AqxZyTsWKT3FSvEhiJvXLxplzslYuj8jr39Rgxj1XU-9Sb4wr8OAAu2JgmuY3Ja1HkzsdkkwzKZdH-P-MVMXWTIg</recordid><startdate>20170519</startdate><enddate>20170519</enddate><creator>Supeł, Karolina</creator><creator>Kacprzak, Michał</creator><creator>Zielińska, Marzenna</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170519</creationdate><title>The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock</title><author>Supeł, Karolina ; Kacprzak, Michał ; Zielińska, Marzenna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-eb1784ff0d62d5770241ca3b6b45443c0aeb8f42554b96d875bc59fa52f91d5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acute Coronary Syndrome - complications</topic><topic>Adrenomedullin - blood</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cardiogenic shock</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>MR-proadrenomedullin</topic><topic>myocardial infarction</topic><topic>Myocardial Infarction - complications</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Protein Precursors - blood</topic><topic>Shock, Cardiogenic - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Supeł, Karolina</creatorcontrib><creatorcontrib>Kacprzak, Michał</creatorcontrib><creatorcontrib>Zielińska, Marzenna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomarkers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Supeł, Karolina</au><au>Kacprzak, Michał</au><au>Zielińska, Marzenna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock</atitle><jtitle>Biomarkers</jtitle><addtitle>Biomarkers</addtitle><date>2017-05-19</date><risdate>2017</risdate><volume>22</volume><issue>3-4</issue><spage>296</spage><epage>303</epage><pages>296-303</pages><issn>1354-750X</issn><eissn>1366-5804</eissn><abstract>Context: Cardiogenic shock (CS) still remains one of the main causes of death in acute myocardial infarction (AMI). Objective: The aim of this study was to evaluate the prognostic value of midregional (MR)-proadrenomedullin in AMI complicated by CS. Methods: Forty-seven consecutive patients were included in our prospective observational study. All patients underwent coronarography and successful percutaneous coronary intervention (PCI). Plasma levels of MR-proADM were measured by a immunofluorescence method. The primary endpoint of the study, defined as cardiovascular death, occurred in 17 patients (36%). Results and conclusion: Elevated plasma level of MR-proADM, determined 24 h after diagnosis of CS could be a predictor of in-hospital mortality in patients with AMI complicated by CS.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>27788594</pmid><doi>10.1080/1354750X.2016.1252962</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1354-750X
ispartof Biomarkers, 2017-05, Vol.22 (3-4), p.296-303
issn 1354-750X
1366-5804
language eng
recordid cdi_crossref_primary_10_1080_1354750X_2016_1252962
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Acute Coronary Syndrome - complications
Adrenomedullin - blood
Adult
Aged
Aged, 80 and over
Cardiogenic shock
Hospital Mortality
Humans
Middle Aged
MR-proadrenomedullin
myocardial infarction
Myocardial Infarction - complications
Prognosis
Prospective Studies
Protein Precursors - blood
Shock, Cardiogenic - complications
title The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A53%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prognostic%20value%20of%20MR-proadrenomedullin%20in%20patients%20with%20acute%20coronary%20syndrome%20complicated%20by%20cardiogenic%20shock&rft.jtitle=Biomarkers&rft.au=Supe%C5%82,%20Karolina&rft.date=2017-05-19&rft.volume=22&rft.issue=3-4&rft.spage=296&rft.epage=303&rft.pages=296-303&rft.issn=1354-750X&rft.eissn=1366-5804&rft_id=info:doi/10.1080/1354750X.2016.1252962&rft_dat=%3Cproquest_cross%3E1835685778%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-eb1784ff0d62d5770241ca3b6b45443c0aeb8f42554b96d875bc59fa52f91d5a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835685778&rft_id=info:pmid/27788594&rfr_iscdi=true